| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
| Insider | Role | Shares | Value | Buys | Sells |
|---|---|---|---|---|---|
| Date | Ticker | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|---|
Salarius Pharmaceuticals, Inc. (DCOY) has 2 insiders with recent SEC Form 4 filings, including 16 buys and 0 sells. DCOY is classified in the Biotechnology industry within the Health Care sector.
| Role | Insider | Shares | Value | 30d |
|---|---|---|---|---|
| CFO | 20.2K | $103.3K | - | |
| Dir | 5.0K | $25.6K | - |
Buys and sells only
| Date | Insider | Role | Type | Shares | Price | Value | Chg% | SEC |
|---|---|---|---|---|---|---|---|---|
| Mar 24, 2016 | Westphal Christoph H | President And CEO | Buy | 49,563 | $11.06 | $548,245.65 | +0.8% | |
| Mar 21, 2016 | Westphal Christoph H | President And CEO | Buy | 48,058 | $11.74 | $564,194.68 | +0.8% | |
| Mar 21, 2016 | Sculley John | Director | Buy | 4,709 | $11.92 | $56,131.17 | +664.2% | |
| Mar 18, 2016 | Westphal Christoph H | President And CEO | Buy | 37,574 | $11.00 | $413,272.00 | +0.7% | |
| Mar 16, 2016 | Westphal Christoph H | President And CEO | Buy | 38,379 | $10.23 | $392,750.64 | +0.7% | |
| Mar 15, 2016 | Stacy Michelle | Director | Buy | 2,585 | $9.63 | $24,893.55 | New | |
| Mar 14, 2016 | Wessel Thomas | Chief Medical Officer | Buy | 20,000 | $7.94 | $158,840.00 | +23.2% | |
| Mar 11, 2016 | Westphal Christoph H | President And CEO | Buy | 89,680 | $7.00 | $627,760.00 | +3.3% | |
| Mar 11, 2016 | Longwood Fund Ii, L.P. | 10% Owner | Buy | 89,680 | $7.00 | $627,760.00 | +3.3% | |
| Mar 11, 2016 | MacKinnon Roderick | Director | Buy | 10,000 | $7.03 | $70,261.00 | +2.4% |